Laryngeal cancer natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (15 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Laryngeal cancer}} | {{Laryngeal cancer}} | ||
{{CMG}} {{AE}}{{Rim}}, {{Faizan}} | {{CMG}} {{AE}} {{OK}}, {{Rim}}, {{Faizan}} | ||
==Overview== | ==Overview== | ||
If left untreated, laryngeal cancer produces few symptoms early in the course. Once the [[tumor]] has expanded from its site of origin, it may obstruct the airway. Common complications of laryngeal cancer include airway obstruction, neck disfigurement, and | If left untreated, [[laryngeal cancer]] produces few [[symptoms]] early in the course. Once the [[tumor]] has expanded from its site of [[origin]], it may obstruct the [[airway]]. Common complications of [[laryngeal cancer]] include [[airway obstruction]], [[neck]] disfigurement, and [[voice]] [[abnormalities]]. The [[prognosis]] varies with the type and stage of [[laryngeal cancer]]. Stage 4 [[squamous cell carcinoma]] of [[larynx]] has the most unfavorable [[prognosis]]. The 3-year survival rate for [[supraglottic laryngeal cancer]] and T3 transglottic [[carcinoma]] are 91.7% and 73.2%, respectively. | ||
==Natural history== | ==Natural history== | ||
The natural history of [[laryngeal carcinoma]] depends on the site:<ref name="pmid7610838">{{cite journal |vauthors=Ferlito A |title=The natural history of early vocal cord cancer |journal=Acta Otolaryngol. |volume=115 |issue=2 |pages=345–7 |date=March 1995 |pmid=7610838 |doi= |url=}}</ref> | |||
== | === Supraglottic tumors <ref name="pmid29155864">{{cite journal |vauthors=Ding W, Liu T, Liang J, Hu T, Cui S, Zou G, Cai W, Yang A |title=Supraglottic squamous cell carcinomas have distinctive clinical features and prognosis based on subregion |journal=PLoS ONE |volume=12 |issue=11 |pages=e0188322 |date=2017 |pmid=29155864 |pmc=5695779 |doi=10.1371/journal.pone.0188322 |url=}}</ref><ref name="pmid1160463">{{cite journal |vauthors=Bocca E |title=Supraglottic cancer |journal=Laryngoscope |volume=85 |issue=8 |pages=1318–26 |date=August 1975 |pmid=1160463 |doi=10.1288/00005537-197508000-00007 |url=}}</ref> === | ||
* More aggressive | |||
*[[ | * Direct extension into the pre-epiglottic space, lateral [[hypopharynx]], [[Glossoepiglottic folds|glossoepiglottic fold]] and the [[tongue]] base and [[lymph nodes]] | ||
=== | === Glottic tumors <ref name="pmid28461858">{{cite journal |vauthors=Zainuddin N, Mohd Kornain NK |title=Glottic cancer in a non-smoking patient with laryngopharyngeal reflux |journal=Malays Fam Physician |volume=11 |issue=2-3 |pages=35–37 |date=2016 |pmid=28461858 |pmc=5408877 |doi= |url=}}</ref><ref name="pmid12057082">{{cite journal |vauthors=Hinerman RW, Mendenhall WM, Amdur RJ, Villaret DB, Robbins KT |title=Early laryngeal cancer |journal=Curr Treat Options Oncol |volume=3 |issue=1 |pages=3–9 |date=February 2002 |pmid=12057082 |doi= |url=}}</ref> === | ||
* Well differentiated | |||
* Less aggressive, they tend to grow slow | |||
* | * [[Metastasize]] late in the [[disease]] | ||
* Extend superiorly into the [[ventricular]] walls or inferiorly into the [[subglottic airway]] | |||
=== Subglottic tumors <ref name="pmid12057082">{{cite journal |vauthors=Hinerman RW, Mendenhall WM, Amdur RJ, Villaret DB, Robbins KT |title=Early laryngeal cancer |journal=Curr Treat Options Oncol |volume=3 |issue=1 |pages=3–9 |date=February 2002 |pmid=12057082 |doi= |url=}}</ref><ref name="pmid1177633">{{cite journal |vauthors=Sessions DG, Ogura JH, Fried MP |title=Carcinoma of the subglottic area |journal=Laryngoscope |volume=85 |issue=9 |pages=1417–23 |date=September 1975 |pmid=1177633 |doi=10.1288/00005537-197509000-00001 |url=}}</ref> === | |||
* Uncommon | |||
* Extends into the [[mediastinum]] | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
* | ==Complications== | ||
Common complications of laryngeal cancer include:<ref name="pmid27841116">{{cite journal |vauthors=Jones TM, De M, Foran B, Harrington K, Mortimore S |title=Laryngeal cancer: United Kingdom National Multidisciplinary guidelines |journal=J Laryngol Otol |volume=130 |issue=S2 |pages=S75–S82 |date=May 2016 |pmid=27841116 |pmc=4873912 |doi=10.1017/S0022215116000487 |url=}}</ref><ref name="pmid26569309">{{cite journal |vauthors=Issa MR, Samuels SE, Bellile E, Shalabi FL, Eisbruch A, Wolf G |title=Tumor Volumes and Prognosis in Laryngeal Cancer |journal=Cancers (Basel) |volume=7 |issue=4 |pages=2236–61 |date=November 2015 |pmid=26569309 |pmc=4695888 |doi=10.3390/cancers7040888 |url=}}</ref> | |||
*[[Airway obstruction]] | |||
*Disfigurement of the [[neck]] or [[face]] | |||
*Loss of [[voice]] and speaking difficulties | |||
*[[Metastasis]] | |||
*A small percentage of patients (5%) will not be able to [[swallow]] and will need to be fed through a [[feeding tube]] | |||
==Prognosis== | |||
* The 3-year survival rate for [[supraglottic laryngeal cancer]] and T3 transglottic [[carcinoma]] is 91.7% and 73.2%, respectively<ref name="pmid14606603">{{cite journal |vauthors=Woo JS, Baek SK, Kwon SY, Jung KY, Lee J |title=T3 supraglottic cancer: treatment results and prognostic factors |journal=Acta Otolaryngol. |volume=123 |issue=8 |pages=980–6 |date=October 2003 |pmid=14606603 |doi= |url=}}</ref> | |||
* [[Laryngeal cancer]] can be cured in 90% of patients if detected early. | |||
* If the [[cancer]] has spread to surrounding [[tissues]] or [[lymph nodes]] in the [[neck]], 50 - 60% of [[patients]] can be cured. | |||
* If the cancer has [[metastasized]] to parts of the body outside the [[head]] and [[neck]], the [[cancer]] is not curable and treatment is aimed at prolonging and improving [[quality of life]]. After treatment, patients generally need therapy to help with [[speech]] and [[swallowing]].<ref name="pmid20530316">{{cite journal |vauthors=Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML |title=Human papillomavirus and survival of patients with oropharyngeal cancer |journal=N. Engl. J. Med. |volume=363 |issue=1 |pages=24–35 |date=July 2010 |pmid=20530316 |pmc=2943767 |doi=10.1056/NEJMoa0912217 |url=}}</ref> | |||
==References== | ==References== | ||
Latest revision as of 06:16, 18 March 2019
|
Laryngeal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Laryngeal cancer natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Laryngeal cancer natural history, complications and prognosis |
|
FDA on Laryngeal cancer natural history, complications and prognosis |
|
CDC on Laryngeal cancer natural history, complications and prognosis |
|
Laryngeal cancer natural history, complications and prognosis in the news |
|
Blogs on Laryngeal cancer natural history, complications and prognosis |
|
Risk calculators and risk factors for Laryngeal cancer natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2], Rim Halaby, M.D. [3], Faizan Sheraz, M.D. [4]
Overview
If left untreated, laryngeal cancer produces few symptoms early in the course. Once the tumor has expanded from its site of origin, it may obstruct the airway. Common complications of laryngeal cancer include airway obstruction, neck disfigurement, and voice abnormalities. The prognosis varies with the type and stage of laryngeal cancer. Stage 4 squamous cell carcinoma of larynx has the most unfavorable prognosis. The 3-year survival rate for supraglottic laryngeal cancer and T3 transglottic carcinoma are 91.7% and 73.2%, respectively.
Natural history
The natural history of laryngeal carcinoma depends on the site:[1]
Supraglottic tumors [2][3]
- More aggressive
- Direct extension into the pre-epiglottic space, lateral hypopharynx, glossoepiglottic fold and the tongue base and lymph nodes
Glottic tumors [4][5]
- Well differentiated
- Less aggressive, they tend to grow slow
- Metastasize late in the disease
- Extend superiorly into the ventricular walls or inferiorly into the subglottic airway
Subglottic tumors [5][6]
- Uncommon
- Extends into the mediastinum
Complications
Common complications of laryngeal cancer include:[7][8]
- Airway obstruction
- Disfigurement of the neck or face
- Loss of voice and speaking difficulties
- Metastasis
- A small percentage of patients (5%) will not be able to swallow and will need to be fed through a feeding tube
Prognosis
- The 3-year survival rate for supraglottic laryngeal cancer and T3 transglottic carcinoma is 91.7% and 73.2%, respectively[9]
- Laryngeal cancer can be cured in 90% of patients if detected early.
- If the cancer has spread to surrounding tissues or lymph nodes in the neck, 50 - 60% of patients can be cured.
- If the cancer has metastasized to parts of the body outside the head and neck, the cancer is not curable and treatment is aimed at prolonging and improving quality of life. After treatment, patients generally need therapy to help with speech and swallowing.[10]
References
- ↑ Ferlito A (March 1995). "The natural history of early vocal cord cancer". Acta Otolaryngol. 115 (2): 345–7. PMID 7610838.
- ↑ Ding W, Liu T, Liang J, Hu T, Cui S, Zou G, Cai W, Yang A (2017). "Supraglottic squamous cell carcinomas have distinctive clinical features and prognosis based on subregion". PLoS ONE. 12 (11): e0188322. doi:10.1371/journal.pone.0188322. PMC 5695779. PMID 29155864.
- ↑ Bocca E (August 1975). "Supraglottic cancer". Laryngoscope. 85 (8): 1318–26. doi:10.1288/00005537-197508000-00007. PMID 1160463.
- ↑ Zainuddin N, Mohd Kornain NK (2016). "Glottic cancer in a non-smoking patient with laryngopharyngeal reflux". Malays Fam Physician. 11 (2–3): 35–37. PMC 5408877. PMID 28461858.
- ↑ 5.0 5.1 Hinerman RW, Mendenhall WM, Amdur RJ, Villaret DB, Robbins KT (February 2002). "Early laryngeal cancer". Curr Treat Options Oncol. 3 (1): 3–9. PMID 12057082.
- ↑ Sessions DG, Ogura JH, Fried MP (September 1975). "Carcinoma of the subglottic area". Laryngoscope. 85 (9): 1417–23. doi:10.1288/00005537-197509000-00001. PMID 1177633.
- ↑ Jones TM, De M, Foran B, Harrington K, Mortimore S (May 2016). "Laryngeal cancer: United Kingdom National Multidisciplinary guidelines". J Laryngol Otol. 130 (S2): S75–S82. doi:10.1017/S0022215116000487. PMC 4873912. PMID 27841116.
- ↑ Issa MR, Samuels SE, Bellile E, Shalabi FL, Eisbruch A, Wolf G (November 2015). "Tumor Volumes and Prognosis in Laryngeal Cancer". Cancers (Basel). 7 (4): 2236–61. doi:10.3390/cancers7040888. PMC 4695888. PMID 26569309.
- ↑ Woo JS, Baek SK, Kwon SY, Jung KY, Lee J (October 2003). "T3 supraglottic cancer: treatment results and prognostic factors". Acta Otolaryngol. 123 (8): 980–6. PMID 14606603.
- ↑ Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (July 2010). "Human papillomavirus and survival of patients with oropharyngeal cancer". N. Engl. J. Med. 363 (1): 24–35. doi:10.1056/NEJMoa0912217. PMC 2943767. PMID 20530316.